Latest News
Inflexion Private Equity has held the first and final close of Inflexion Enterprise Fund IV and Inflexion Supplemental Fund IV, securing commitments of GBP250 million for each new fund.
Raised exclusively from Inflexion’s existing LP base of blue chip investors from across Europe, the US and Asia, both funds reached their respective hard caps in a single closing, within just eight weeks of launch. In keeping with previous fundraisings, Inflexion closed on timetable and without the support of a placement agent.
Inflexion Enterprise Fund IV, the fourth generation of Inflexion funds focused on the UK lower mid-market, will follow
Independent investment banking firm Freitag & Co is expanding its advisory board with the addition of Robert Steven Miller, Dr Stefan Schmittmann and Matthias Wissmann, effective 1 June.
Professor Dr Hans-Jörg Bullinger, Chairman of the advisory board, says: ”The experience and calibres of our new board members are a perfect match with the competence and positioning of Freitag & Co. We look forward to working with them.“
As CEO or Chairman Miller has restructured AIG, Bethlehem Steel, Chrysler Corporation (Vice Chairman), Delphi, Federal Mogul, Hawker Beechcraft or United Airlines (Director). Currently, he is CEO of IAC, Luxembourg. Miller is a
Funds advised by CVC Capital Partners (CVC) are to acquire 100 per cent of ÅR Packaging Group AB (AR Packaging) from Ahlstrom Capital and Accent Equity.
Founded in 2011 through the merger of A&R Carton and Flextrus, AR Packaging is one of Europe’s leading packaging companies with sales of approximately EUR560 million (pro forma 2015) and 2,200 employees across 17 factories in 9 countries. The company has performed strongly in recent years, posting a 27 per cent increase in net sales last year.
Headquartered in Lund, Sweden, the group is divided into three divisions: Branded Products, Barrier Packaging and Food
Arma Partners has acted as exclusive financial advisor to TeacherMatch, a portfolio company of Prairie Capital, on its sale to PeopleAdmin, a portfolio company of Vista Equity Partners.
TeacherMatch provides cloud-based recruitment, screening, professional development and workforce planning solutions for K-12 school districts and offers the only data-driven, research-based and analytically predictive teacher assessment tool.
This transaction highlights Arma Partners’ continued expertise in HCM and Talent Management Software, the Ed-tech Sector and SaaS M&A and our exceptional track record of working with Private Equity-backed companies.
A new study from specialist lending firm, Amicus, reveals that one in six (16 per cent) small and medium sized enterprise (SME) owners seeking finance say they have been turned down by a mainstream lender, such as a high street bank, up from 11 per cent in 2015.
Nearly a third (31 per cent) of SME owners reported that their inability to secure finance terms with a mainstream lender meant they had lost out on a business deal or investment opportunity. As a result, this has led to greater interest in alternative finance – including forms such as property finance,
Baltic private equity house BaltCap has acquired a majority stake in the leading Estonian occupational health care company Qvalitas Arstikeskus AS (Qvalitas).
BaltCap Private Equity Fund II (BPEF II) signed an agreement to acquire 72 per cent of Qvalitas. The remaining 28 per cent are held by the management team. In addition to BPEF II, Erki Mölder, the CEO of Unimed Group is an investor in the holding company carrying out the transaction.
Qvalitas was founded in 1996 and it offers occupational heath care as well as general and specialised medical services in Estonia. The company is mainly known
The Standard Life European Private Equity Trust (SLEPET) has reported net asset value (NAV) total return for the six months to 31 March 2016 of 11.3 per cent. NAV total return for the 12 months to 31 March 2016 was 17.4 per cent.
The NAV at 31 March 2016 rose 10.2 per cent to 310.2p (30 September 2015; 281.6p) including the payment of a final dividend of 3.5p per ordinary share for the year ended 30 September 2015 in the period.
The Board has declared an interim dividend of 1.80p to be paid on 15 July 2016. It remains
Aleva Neurotherapeutics, a developer of next-generation implants for deep brain stimulation (DBS) in major neurological indications such as Parkinson’s Disease and Essential Tremor, has raised USD 18 million in a Series C financing round.
The round was led by Greatbatch (NYSE:GB), a strategic lead investor contributing a total of USD5 million to the transaction. In February 2016, Aleva and Greatbatch announced the closing of a strategic development, supply and manufacturing agreement. In addition, Aleva will combine their innovative directional lead technology with the proprietary neurostimulation platform of Nuvectra, a recent spin-off from Greatbatch.
Aleva’s existing investors (BioMedPartners, BB Biotech Ventures,
Mid-market private equity firm LDC has backed the GBP22m management buyout of global ID cards business, Magicard, from listed defence and security group Ultra Electronics Holdings plc.
Founded in 1992, Magicard is one of the world’s leading manufacturers of secure desktop ID card printers, software and related consumables for the identity and access control markets. Its products, which include direct-to-card and retransfer printers, are capable of printing and encoding all types of card format, including magnetic stripe, proximity cards and ‘chip and pin’ cards used in the banking sector. Magicard printers are renowned for their built-in card security features, including
Amulet Capital Partners (Amulet), a middle-market private equity investment firm focused exclusively on the healthcare sector, has acquired SynteractHCR Holdings Corporation (SynteractHCR), a contract research organisation (CRO) focused on Phase I‐IV clinical trials for emerging to mid-sized biopharma clients in the US, Europe and Asia.
Terms of the transaction have not been disclosed.
Headquartered outside San Diego, California, SynteractHCR was founded in 1995 and is now a top 20 global full‐service CRO. The company has over 800 staff members across 21 countries. SynteractHCR has a reputation for clinical excellence in complex trials in a broad range of therapeutic areas, contributing
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
